Cargando…
Malondialdehyde mediates oxidized LDL-induced coronary toxicity through the Akt-FGF2 pathway via DNA methylation
BACKGROUND: Oxidized LDL (oxLDL) is involved in the development of atherosclerotic heart disease through a mechanism that is not fully understood. In this study, we examined the role of malondialdehyde (MDA), an important oxidative stress epitope of oxLDL, in mediating coronary endothelial cytotoxic...
Autores principales: | Yang, Tzu-Ching, Chen, Yi-Jie, Chang, Shwu-Fen, Chen, Chu-Huang, Chang, Po-Yuan, Lu, Shao-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931320/ https://www.ncbi.nlm.nih.gov/pubmed/24490960 http://dx.doi.org/10.1186/1423-0127-21-11 |
Ejemplares similares
-
Circulating Malondialdehyde-Modified LDL-Related Variables and Coronary Artery Stenosis in Asymptomatic Patients with Type 2 Diabetes
por: Fujihara, Kazuya, et al.
Publicado: (2015) -
Malondialdehyde-Modified LDL IgG Antibody Levels and Indices of Cardiac Function in Valvular Heart and Coronary Artery Disease Patients
por: Rahsepar, Amir Ali, et al.
Publicado: (2015) -
The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
por: Hartley, Adam, et al.
Publicado: (2021) -
Combined LDL and VLDL Electronegativity Correlates with Coronary Heart Disease Risk in Asymptomatic Individuals
por: Shen, Ming-Yi, et al.
Publicado: (2019) -
Using Anti-Malondialdehyde Modified Peptide Autoantibodies to Import Machine Learning for Predicting Coronary Artery Stenosis in Taiwanese Patients with Coronary Artery Disease
por: Hsu, Yu-Cheng, et al.
Publicado: (2021)